To avoid differences resulting from tumor heterogeneity, we also analysed the prognostic value of ANXA2 expression in low-grade glioma (LGG) (Fig. 2C,D) and HGG (Fig. 2E,F) among patients in the two datasets, and the conclusions were similar. The gene discussed is ANXA2; the disease is neoplasm.